Paola Tello Valverde: The significance of hyperthermia in postoperative re-irradiation for patients with locally recurrent breast cancer
Paola Tello Valverde, Co-founder of Jump18-Aruba Childhood Obesity Prevention Program, shared a post on LinkedIn about a paper she co-authored with colleagues published in International Journal of Radiation Oncology, Biology, Physics:
“I am delighted to share that we have reached a significant milestone.
One of my most important investigations, ‘The probability of locoregional control in patients with locoregional recurrent breast cancer treated with postoperative re-irradiation and hyperthermia (RADHY): A continuous thermal dose-effect relationship’, has been recently published in the esteemed IJROBP The Red Journal.
The study establishes a consistent thermal dose-effect relationship, offering valuable insights into the effectiveness of this treatment approach for patients who underwent postoperative re-irradiation combined with hyperthermia.
A significant relationship was observed between an increased thermal dose and an improved locoregional control, varying from ~44% to -98% at 5 years, underscoring the importance of ensuring adequate thermal dose.
This finding reinforces the significance of hyperthermia in enhancing the potent sensitizing effect of postoperative re-irradiation for patients with locally recurrent breast cancer.
I want to express my deepest gratitude to all my co-authors Konstantinos Pateras, Akke Bakker, Polychronis Kostoulas, Willemijn Kolff, Petra Kok, Geertjan van Tienhoven, my promoter Ben Slotman and my co-promoter Hans Crezee. Thank you all so much for your support and collaboration.”
Authors: Paola Tello Valverde, Akke Bakker, Petra Kok, Willemijn Kolff, Geertjan van Tienhoven, Polychronis Kostoulas, Ben Slotman, Konstantinos Pateras, and Hans Crezee.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023